ICICI Lombard General Insurance has disclosed its schedule of analyst and institutional investor meetings for November 2026. The insurer plans to hold five in-person engagements in Mumbai, ranging from group discussions with Bernstein to major industry conferences.

The disclosure was made pursuant to Regulation 30 read with Schedule III and Regulation 46(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information would be shared during these interactions. All disclosures are available on the company's official website.

Meeting schedule details

The upcoming engagements include a mix of group meetings with fund managers and participation in prominent financial forums. The schedule highlights ICICI Lombard's active engagement with the institutional investor community in the capital markets hub of Mumbai.

The company noted that the scheduled meetings remain subject to changes due to exigencies on the part of analysts, investors, or the company itself.

ICICI Lombard General Insurance Company Limited reported a 15.47% year-on-year increase in net profit for the quarter ended September 30, 2026. The insurer recorded a Profit After Tax (PAT) of ₹9.46 billion, up from ₹8.20 billion in the corresponding period last year. The Board also approved an interim dividend of ₹7 per equity share.

Gross Direct Premium Income (GDPI) on a 1/n basis rose 4.7% YoY to ₹72.84 billion, while GDPI excluding Crop and Mass Health grew 13.9%, outpacing industry growth of 13.2%. Total income stood at ₹784,372 lakh, reflecting 19.16% growth from ₹658,267 lakh recorded in Q2FY26. Despite top-line growth, the underwriting loss widened to ₹31,838 lakh from ₹17,836 lakh in the previous year, an increase of approximately 78.5%.

Financial Performance Highlights

The company's operational metrics showed mixed trends, with strong premium collection accompanied by higher claims and expenses. The incurred claim ratio increased slightly to 72.2% from 72.1% YoY, while the combined ratio worsened to 107.0% from 105.1%. On a 1/n basis, the combined ratio was 104.5% in Q2FY27 against 103.9% in Q2FY26. Excluding CAT losses of ₹1.18 billion in Q2FY27 and ₹0.73 billion in Q2FY26, the combined ratios were 102.7% and 102.6%, respectively.

Segment-wise Growth

The company maintained a market share of 10.3% in Motor in H1FY27. Motor GDPI grew 13.0% in H1FY27, compared with industry growth of 13.1%. In the Health segment, ICICI Lombard grew 26.8% in Q2FY27, compared with industry growth of 18.9%. Retail Health recorded growth of 64.0% in Q2FY27, against industry growth of 32.3%. In the Commercial segment, Fire declined 21.2% in Q2FY27, while Commercial lines excluding Fire registered growth of 20.0%.

Management Commentary on Key Issues

During the earnings conference call held on October 14, 2026, management addressed several critical operational and regulatory topics.

Supreme Court Judgment Impact

Management clarified that the incremental reserving requirement of ₹1.65 billion recognized in Q1FY27 following the Supreme Court's Shishupal judgment on unpaid domestic work compensation is now fully integrated into business-as-usual operations. CFO Gopal Balachandran stated that no further specific provisions are anticipated for this issue, as the initial provision was based on prudent estimates. The company continues to monitor long-tail claim development but considers the current accounting treatment sufficient.

Distribution Reforms and IRDAI Consultation

MD & CEO Sanjeev Mantri described the IRDAI consultation paper "Recalibrating Economics of Insurance Distribution" as a landmark change expected to simplify structures and improve accessibility. He noted that while lower commissions could theoretically reduce third-party tariff pressures, the final outcome remains subject to regulatory discussions. The management emphasized that ICICI Lombard has consistently maintained its Expense of Management (EOM) within the 30% regulatory limit, positioning it favorably if the proposed 25% cap is implemented, as competitors operating above current limits may face greater adjustment challenges.

Motor Underwriting Discipline

The management highlighted a widening divergence between ICICI Lombard’s Motor Combined Ratio and the industry average. While the industry Motor Combined Ratio deteriorated to 131.4% in Q1FY27 (from 125.0% in Q1FY26), ICICI Lombard’s ratio moved only marginally to 108.3% (from 107.6%). This resulted in a delta of 23.1 percentage points, up from 17.4 points in the prior year period, underscoring superior underwriting discipline and claims management.

Brokerage Views and Valuation

Following the results, HSBC maintained a Hold rating on the stock but raised its target price to ₹1,820. The brokerage noted that Q2FY27 PAT beat estimates due to higher retention and investment income, while the core combined operating ratio remained stable YoY. HSBC raised FY27–29 EPS estimates by 0–2%, noting that regulatory uncertainty remains a risk, though valuation appears to reflect the company’s ability to outperform peers.

Goldman Sachs maintained a Neutral rating with a target price of ₹1,880. The firm highlighted that Q2 gross direct premium income grew 3% YoY, below industry growth of around 7%, with Health up 27% and Motor up 12%, partly offset by a 13% decline in Fire. Goldman observed that the combined ratio worsened around 200 bps to 107% due to catastrophe losses and higher claims, prompting FY27–29 EPS cuts of up to 2%.

Dividend Declaration and TDS Details

The Board approved an interim dividend of ₹7 per equity share (70% of the face value of ₹10). This payout is for the financial year ending March 31, 2027. Shareholders whose names appear in the Register of Members or depository records as beneficial owners on Friday, October 23, 2026, will be eligible. The dividend will be paid on or before November 12, 2026.

The Company has issued a communication regarding Tax Deduction at Source (TDS) on this dividend. For resident individual shareholders, TDS is applicable at 10% on the dividend amount, provided a valid PAN is submitted. If PAN is not provided or is inoperative, TDS applies at 20%. No tax shall be deducted if the total dividend payable does not exceed ₹10,000 per year, or if the shareholder submits Form 121 with valid PAN and meets eligibility conditions. Non-resident shareholders are subject to TDS rates under Section 393(2) read with Section 207 of the Income-tax Act, 2025, currently at 20%, or lower rates as per applicable Double Tax Avoidance Agreements (DTAA), subject to submission of required documents like Tax Residency Certificates and Form 41.

Shareholders must submit relevant tax-related documents to KFin Technologies Limited (the RTA) or their Depository Participants by the record date, October 23, 2026, to ensure correct tax deduction. Failure to provide these details may result in higher TDS deduction, though shareholders can still claim refunds via their income tax returns.

What the Numbers Show

The company's premium growth was accompanied by a widening underwriting loss. While net premiums increased by nearly 17%, the underwriting loss widened by approximately 78.5% to ₹31,838 lakh from ₹17,836 lakh. Commission and brokerage expenses rose 25.26% YoY to ₹126,861 lakh, exceeding the 17.7% growth in net earned premiums. Higher commission expenses may have contributed to underwriting pressure, although claims, operating expenses and other underwriting items also affect the overall result.

Investment income stood at ₹15.54 billion in Q2FY27, compared with ₹12.49 billion in Q2FY26. Capital gains also increased to ₹4.53 billion, supporting profitability despite the underwriting loss. The financial statements should be checked to confirm whether capital gains are included in the reported investment income.

Additionally, the company recognized claim reserves amounting to ₹16,940 lakh for the period ended September 30, 2026, following the Supreme Court's June 11, 2026 judgment concerning compensation for unpaid domestic work in Motor Third-Party claims. This provision includes ₹16,500 lakh pertaining to the previous quarter ended June 30, 2026.

Balance Sheet and Cash Flow

The company reported a solvency ratio of 2.75x, up from 2.73x in the previous year. On a 1/n basis, the solvency ratio was 2.74x as of September 30, 2026, compared with 2.68x as of June 30, 2026. However, cash flow from operating activities turned negative at ₹(38,366) lakh for the half-year ended September 30, 2026, compared with positive cash flow of ₹45,946 lakh in the same period last year. Claim payments increased to ₹934,369 lakh from ₹780,486 lakh. Higher claim payments and commission payouts may have contributed to the decline, although the full explanation should be verified against the company's cash-flow statement.